Objectives: We sought to determine the predictors of stent thrombosis after sirolimus-eluting
stent (SES) implantation. Background: A number of cases of stent thrombosis have been …

Intravascular ultrasound (IVUS) evaluation was performed in 33 lesions with sirolimus-
eluting stent (SES) failure: 4 thromboses, 26 in-stent restenoses (including 6 edge …

Aims In many countries, drug-eluting stent implantation is the dominant interventional
strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound …

Background—Stent thrombosis may occur late after drug-eluting stent (DES) implantation,
and its cause remains unknown. The present study investigated differences of the stented …

Background—Intraprocedural stent thrombosis (IPST) is a rare event (< 0.01% in our
experience with bare metal stents), with the exception of specific settings such as acute …

Background—Stent thrombosis (ST) is a rare but devastating complication of coronary stent
implantation, occurring in 0.5% to 1.9% of patients with bare metal stents. The incidence of …

Objectives: We compared intravascular ultrasound findings of drug-eluting stent (DES)–
treated lesions that developed thrombosis versus in-stent restenosis (ISR). Background …

Background—Little is known about causes of intimal hyperplasia (IH) after sirolimus-eluting
stent (SES) implantation. Methods and Results—Intravascular ultrasound was performed in …

Objectives: We sought to identify the frequency of incomplete stent apposition (ISA) in
sirolimus-eluting stents (SES) and clarify its findings and clinical sequelae. Background …

Objectives and background The impact of underexpansion and minimal stent area (MSA)
criteria in the second generation drug‐eluting stents (DES) has not been addressed yet …